Study for Treatment of Chronic Diabetic Foot Ulcers With the Investigational Allogeneic Cell Therapy Product, hOMSC200

NCT06003530 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot
Diabetic Foot Ulcer
Diabetic Foot Ulcer Neuropathic

Interventions

BIOLOGICAL: hOMSC200
OTHER: Placebo

Sponsor

Cytora Ltd.